Literature DB >> 1721348

Retransplantation of liver: a comparison of FK 506- and cyclosporine-treated patients.

S Takaya1, O Bronsther, S Todo, K Abu-Elmagd, A Jain, M Alessiani, J Madariaga, I R Marino, R Selby, J J Fung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721348      PMCID： PMC3154773     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

1.  Hepatic Retransplantation.

Authors:  B W Shaw; R D Gordon; S Iwatsuki; T E Starzl
Journal:  Transplant Proc       Date:  1985-02       Impact factor: 1.066

2.  Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution.

Authors:  H Furukawa; S Todo; O Imventarza; A Casavilla; Y M Wu; C Scotti-Foglieni; B Broznick; J Bryant; R Day; T E Starzl
Journal:  Transplantation       Date:  1991-05       Impact factor: 4.939

3.  Protective effect of FK 506 against hepatic ischemia in rats.

Authors:  M F Sakr; G M Zetti; H Farghali; T H Hassanein; J S Gavaler; T E Starzl; D H Van Thiel
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

4.  Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy.

Authors:  S Takaya; R Duquesnoy; Y Iwaki; J Demetris; A Yagihashi; O Bronsther; S Iwatsuki; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

Review 5.  Evolution of liver transplantation.

Authors:  T E Starzl; S Iwatsuki; D H Van Thiel; J C Gartner; B J Zitelli; J J Malatack; R R Schade; B W Shaw; T R Hakala; J T Rosenthal; K A Porter
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

6.  Augmentation of rat liver regeneration by FK 506 compared with cyclosporin.

Authors:  A Francavilla; M Barone; S Todo; Q Zeng; K A Porter; T E Starzl
Journal:  Lancet       Date:  1989-11-25       Impact factor: 79.321
  6 in total
  4 in total

1.  Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation.

Authors:  S Takaya; H Doyle; S Todo; W Irish; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1995-04       Impact factor: 1.066

2.  The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation.

Authors:  F Greif; O L Bronsther; D H Van Thiel; A Casavilla; S Iwatsuki; A Tzakis; S Todo; J J Fung; T E Starzl
Journal:  Ann Surg       Date:  1994-01       Impact factor: 12.969

Review 3.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

4.  Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial.

Authors:  D H Van Thiel; H Wright; P Carroll; K Abu-Elmagd; H Rodriguez-Rilo; J McMichael; W Irish; T E Starzl
Journal:  Am J Gastroenterol       Date:  1995-05       Impact factor: 10.864
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.